Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Gefticip 250mg Tablets:
Gefticip Tablet is prescribed for the treatment of non-small cell lung cancer. It is particularly effective for patients whose cancer has metastasized to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not undergone prior treatment for cancer.
Administration of Gefticip 250mg Tablets:
Gefticip Tablet can be taken with or without food, although taking it at the same time every day is recommended for optimal results. It is important to continue taking the medication for as long as your doctor advises. The duration of treatment varies depending on your individual needs and response to therapy. Take the medication exactly as prescribed by your doctor, as taking too much can lead to severe side effects. It may take several weeks or months to see or feel the benefits, so do not discontinue the medication unless instructed by your doctor.
Uses of Gefticip 250mg Tablets:
Gefticip 250mg Tablets are primarily used for:
Non-small cell lung cancer
Benefits of Gefticip 250mg Tablets:
In Non-small Cell Lung Cancer:
Non-small cell lung cancer is a major type of lung cancer that affects both smokers and non-smokers. Gefticip Tablet helps treat non-small cell lung cancer and may be administered alone or in combination with other medications. It is a potent and highly effective drug, and it's important to discuss the risks and benefits with your doctor. Avoiding alcohol consumption while undergoing this treatment and staying hydrated by drinking plenty of water is recommended.
Mechanism of Action of Gefticip 250mg Tablets:
Gefticip Tablet is an anti-cancer medication that works by inhibiting the action of abnormal proteins that signal cancer cells to multiply. This helps to halt or slow down the spread of cancer cells.